These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
22-3956444
|
|
(State or other jurisdiction of incorporation
or organization)
|
(I.R.S. Employer Identification
No.)
|
|
Large accelerated filer
o
|
Accelerated filer
o
|
|
Non-accelerated filer
o
(Do not check if smaller reporting company)
|
Smaller reporting company
x
|
|
Page
|
||
|
|
||
|
Item 1.
|
Financial Statements (unaudited)
|
|
|
Condensed Consolidated Balance Sheets
|
3
|
|
|
Condensed Consolidated Statements of Operations
|
4
|
|
|
Condensed Consolidated Statements of Cash Flows
|
5
|
|
|
Notes to Interim Condensed Consolidated Financial Statements
|
6
|
|
|
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
20
|
|
Item 4.
|
Controls and Procedures
|
26
|
|
|
||
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
27
|
|
Item 3.
|
Defaults Upon Senior Securities
|
27
|
|
Item 4.
|
Mine Safety Disclosures
|
27
|
|
Item 6.
|
Exhibits
|
28
|
|
SIGNATURES
|
29
|
|
|
U-VEND, INC.
|
||||||||
|
|
||||||||
|
As of
|
||||||||
|
September 30,
|
December 31,
|
|||||||
|
2015
|
2014
|
|||||||
|
(Unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
Current assets:
|
||||||||
|
Cash
|
$ | 89,765 | $ | 73,396 | ||||
|
Accounts receivable
|
7,793 | - | ||||||
|
Inventory (net)
|
43,139 | 28,732 | ||||||
|
Prepaid expenses and other assets
|
109,217 | 130,081 | ||||||
|
Total current assets
|
249,914 | 232,209 | ||||||
|
Noncurrent assets:
|
||||||||
|
Property and equipment (net)
|
708,679 | 675,772 | ||||||
|
Security deposits
|
15,943 | 7,171 | ||||||
|
Deferred financing costs (net)
|
55,998 | 73,139 | ||||||
|
Intangible asset (net)
|
282,101 | 347,201 | ||||||
|
Goodwill
|
642,340 | 642,340 | ||||||
|
Total noncurrent assets
|
1,705,061 | 1,745,623 | ||||||
|
Total assets
|
$ | 1,954,975 | $ | 1,977,832 | ||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIENCY
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$ | 269,953 | $ | 187,460 | ||||
|
Accrued expenses
|
126,483 | 124,676 | ||||||
|
Accrued interest
|
124,650 | 90,797 | ||||||
|
NHL sponsorship liability
|
230,004 | - | ||||||
|
Contingent consideration
|
- | 226,866 | ||||||
|
Registration rights liability
|
22,156 | 22,156 | ||||||
|
Amounts due to officers
|
588,756 | 380,442 | ||||||
|
Senior convertible notes, net of discount
|
357,756 | 319,014 | ||||||
|
Promissory notes payable
|
420,603 | 304,277 | ||||||
|
Convertible notes payable, net of discount
|
695,218 | 303,074 | ||||||
|
Current capital lease obligation
|
94,989 | 116,000 | ||||||
|
Total current liabilities
|
2,930,568 | 2,074,762 | ||||||
|
Noncurrent liabilities:
|
||||||||
|
Contingent consideration
|
- | 246,423 | ||||||
|
Capital lease obligation, net of discount
|
252,135 | 280,959 | ||||||
|
Warrant liabilities
|
303,912 | 309,993 | ||||||
|
Total noncurrent liabilities
|
556,047 | 837,375 | ||||||
|
Total liabilities
|
3,486,615 | 2,912,137 | ||||||
|
Commitments and contingencies (Note 8)
|
||||||||
|
Stockholders' deficiency:
|
||||||||
|
Common stock, $.001 par value, 600,000,000 shares
|
||||||||
|
authorized, 15,904,232 shares issued and outstanding
|
||||||||
|
(10,151,390 - 2014)
|
15,902 | 10,151 | ||||||
|
Additional paid-in capital
|
3,661,070 | 2,832,392 | ||||||
|
Accumulated deficit
|
(5,208,612 | ) | (3,776,848 | ) | ||||
|
Total stockholders' deficiency
|
(1,531,640 | ) | (934,305 | ) | ||||
|
Total liabilities and stockholders' deficiency
|
$ | 1,954,975 | $ | 1,977,832 | ||||
|
The accompanying notes are an integral part of the condensed consolidated financial statements
|
||||||||
|
U-VEND, INC.
|
||||||||||||||||
|
|
||||||||||||||||
|
Unaudited
|
||||||||||||||||
|
For the Three Months Ended
|
For the Nine Months Ended
|
|||||||||||||||
|
September 30, 2015
|
September 30, 2014
|
September 30, 2015
|
September 30, 2014
|
|||||||||||||
|
Revenue
|
$ | 275,266 | $ | 86,530 | $ | 624,478 | $ | 182,166 | ||||||||
|
Cost of revenue
|
187,699 | 50,874 | 402,968 | 104,855 | ||||||||||||
|
Gross profit
|
87,567 | 35,656 | 221,510 | 77,311 | ||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Selling
|
248,565 | 114,479 | 623,321 | 303,803 | ||||||||||||
|
General and administrative
|
441,515 | 273,902 | 1,028,341 | 836,250 | ||||||||||||
|
Accretion and reversal of earn-out liability
|
- | - | (201,013 | ) | - | |||||||||||
| 690,080 | 388,381 | 1,450,649 | 1,140,053 | |||||||||||||
|
Operating loss
|
(602,513 | ) | (352,725 | ) | (1,229,139 | ) | (1,062,742 | ) | ||||||||
|
Other (income) expense, net
|
||||||||||||||||
|
(Gain) loss on the change in fair value of debt and warrant liabilities
|
(32,042 | ) | (219,888 | ) | (67,743 | ) | 57,786 | |||||||||
|
Amortization of debt discount and deferred financing costs
|
(333 | ) | 137,252 | 114,620 | 372,333 | |||||||||||
|
Interest expense
|
57,503 | 45,638 | 180,309 | 110,254 | ||||||||||||
|
Loss (gain) on extinguishment of debt
|
- | 7,632 | - | (114,266 | ) | |||||||||||
|
Unrealized gain on foreign currency
|
(8,602 | ) | (12,500 | ) | (24,561 | ) | (12,500 | ) | ||||||||
| 16,526 | (41,866 | ) | 202,625 | 413,607 | ||||||||||||
|
Loss before income taxes
|
(619,039 | ) | (310,859 | ) | (1,431,764 | ) | (1,476,349 | ) | ||||||||
|
Income tax benefit
|
- | 24,738 | - | 24,738 | ||||||||||||
|
Net loss
|
$ | (619,039 | ) | $ | (286,121 | ) | $ | (1,431,764 | ) | $ | (1,451,611 | ) | ||||
|
Net loss per share- basic and diluted
|
$ | (0.04 | ) | $ | (0.03 | ) | $ | (0.11 | ) | $ | (0.18 | ) | ||||
|
Weighted average common shares outstanding - basic and diluted
|
15,213,660 | 9,167,005 | 13,246,165 | 8,176,201 | ||||||||||||
|
The accompanying notes are an integral part of the condensed consolidated financial statements
|
||||||||||||||||
|
U-VEND, INC.
|
||||||||
|
|
||||||||
|
Unaudited
|
||||||||
|
For the Nine Months Ended
|
||||||||
|
September 30, 2015
|
September 30, 2014
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net loss
|
$ | (1,431,764 | ) | $ | (1,451,611 | ) | ||
|
Adjustments to reconcile net loss to net cash used by operating activities:
|
||||||||
|
Stock based compensation
|
112,431 | 146,533 | ||||||
|
(Gain) loss on fair value of warrant liabilities
|
(62,343 | ) | 81,224 | |||||
|
Common shares issued for lease obligation
|
28,187 | 17,658 | ||||||
|
Common shares and warrants issued for services
|
195,473 | 285,132 | ||||||
|
Depreciation
|
90,058 | 43,324 | ||||||
|
Amortization of intangible assets
|
65,100 | 65,099 | ||||||
|
Amortization of debt discount and deferred financing costs
|
114,620 | 372,333 | ||||||
|
Accretion of contingent consideration, net of fair value adjustment
|
(201,013 | ) | (4,215 | ) | ||||
|
Unrealized gain on foreign currency
|
(24,561 | ) | (12,500 | ) | ||||
|
Benefit recognized on deferred taxes
|
- | (24,738 | ) | |||||
|
Convertible notes payable fair value adjustment
|
(5,400 | ) | (23,438 | ) | ||||
|
Common shares issued to obtain loan from lessor
|
- | 10,000 | ||||||
|
Conversion of accrued interest to common stock
|
- | 500 | ||||||
|
Gain on extinguishment of debt
|
- | (114,266 | ) | |||||
|
(Increase) decrease in assets:
|
||||||||
|
Accounts receivable
|
(7,793 | ) | - | |||||
|
Inventory
|
(14,407 | ) | (13,026 | ) | ||||
|
Prepaid expenses and other assets
|
12,092 | 1,199 | ||||||
|
Increase in liabilities:
|
||||||||
|
Accounts payable and accrued expenses
|
373,259 | 193,830 | ||||||
|
Accrued interest
|
113,693 | - | ||||||
|
Amount due to officers
|
208,314 | 85,367 | ||||||
|
Net cash used by operating activities
|
(434,054 | ) | (341,595 | ) | ||||
|
Cash flows from investing activities:
|
||||||||
|
Purchase of property and equipment
|
(7,115 | ) | (7,548 | ) | ||||
|
Acquisition of business
|
- | 11,130 | ||||||
|
Net cash (used) provided by investing activities
|
(7,115 | ) | 3,582 | |||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from common stock warrant exercises
|
55,000 | 71,660 | ||||||
|
Proceeds from senior convertible notes, net of financing costs
|
- | 121,344 | ||||||
|
Proceeds from convertible notes, net of financing costs
|
423,900 | 115,082 | ||||||
|
Proceeds from promissory notes
|
48,838 | 10,000 | ||||||
|
Principal payments on promissory notes
|
- | (2,754 | ) | |||||
|
Proceeds from notes payable director
|
- | 50,000 | ||||||
|
Repayment of convertible note
|
(70,200 | ) | - | |||||
|
Net cash provided by financing activities
|
457,538 | 365,332 | ||||||
|
Net increase in cash
|
16,369 | 27,319 | ||||||
|
Cash - beginning of period
|
73,396 | 14,620 | ||||||
|
Cash - end of period
|
$ | 89,765 | $ | 41,939 | ||||
|
Cash paid for :
|
||||||||
|
Income taxes
|
$ | 3,700 | $ | 2,000 | ||||
|
Interest
|
$ | 23,000 | $ | 16,958 | ||||
|
Non-cash investing and financing activities:
|
||||||||
|
Property and equipment financed with financing obligation
|
$ | 65,750 | $ | - | ||||
|
Property and equipment financed with capital lease
|
$ | - | $ | 271,572 | ||||
|
Equipment acquired in exchange of warrant liability
|
$ | 50,100 | $ | - | ||||
|
Debt discount related to warrant liability and beneficial conversion feature
|
$ | 9,696 | $ | 387,942 | ||||
|
Issuance of promissory notes offsetting accrued expenses
|
$ | 60,000 | $ | 57,807 | ||||
|
Issuance of common stock to satisfy capital lease obligation
|
$ | 136,334 | $ | 49,586 | ||||
|
Issuance of common shares to satisfy contingent consideration obligation
|
$ | 272,276 | $ | - | ||||
|
Acquisition of U-Vend, Inc. for issuance of shares and effective settlement of inter-company
|
$ | - | $ | 808,349 | ||||
|
Settlement of notes payable director in common shares and warrants
|
$ | - | $ | 150,062 | ||||
|
Issuance of common shares and warrants as debt financing cost
|
$ | 26,195 | $ | - | ||||
|
Reclassification of warrant liability to paid in capital- adequate authorized shares available
|
$ | - | $ | 52,833 | ||||
|
Conversion convertible debt into common stock
|
$ | 5,000 | $ | - | ||||
|
The accompanying notes are an integral part of the condensed consolidated financial statements
|
||||||||
|
·
|
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
|
|
·
|
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
|
·
|
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
|
Consideration
:
|
||||
|
Fair value of 3,500,000 shares of common stock issued at $0.14 on January 7, 2014
|
$
|
490,000
|
||
|
Fair value of 4,522,850 shares of common stock measured at $0.14, discounted for the probability of achievement
|
246,568
|
|||
|
736,568
|
||||
|
Discount for restrictions
|
(103,118
|
)
|
||
|
Effective settlement of intercompany payable due to U-Vend, Inc.
|
174,899
|
|||
|
Total purchase price
|
$
|
808,349
|
||
|
Cash
|
$
|
11,132
|
||
|
Inventory
|
15,253
|
|||
|
Prepaid expense
|
350
|
|||
|
Property and equipment
|
232,835
|
|||
|
Security deposits
|
6,631
|
|||
|
Intangible assets- Operating Agreement
|
434,000
|
|||
|
Goodwill
|
642,340
|
|||
|
Accounts payable and accrued expenses
|
(135,634)
|
|||
|
Notes payable
|
(170,517)
|
|||
|
Capital lease obligations
|
(153,041)
|
|||
|
Deferred tax liability
|
(75,000)
|
|||
|
Total purchase price
|
$
|
808,349
|
|
2015
|
68,178
|
|||
|
2016
|
126,822
|
|||
|
2017
|
25,831
|
|||
|
Total minimum lease payments
|
220,831
|
|||
|
Guaranteed residual value
|
206,833
|
|||
|
427,664
|
||||
|
Less: Amount represented interest
|
(53,984
|
)
|
||
|
Present value of minimum lease payments and guaranteed residual value
|
373,680
|
|||
|
Less: Current portion of capital lease obligations
|
(94,989
|
)
|
||
|
Long term capital lease obligations and guaranteed residual value
|
278,691
|
|||
|
Less: Unamortized debt discount on capital leases
|
(26,556
|
)
|
||
|
Long term capital lease obligations and guaranteed residual value, net
|
$
|
252,135
|
|
Shares Outstanding
|
Common Stock
|
Additional Paid-in Capital
|
Accumulated Deficit
|
Total Stockholders’ Deficiency
|
||||||||||||||||
|
Balance at December 31, 2014
|
10,151,390
|
$
|
10,151
|
$
|
2,832,392
|
$
|
(3,776,848)
|
$
|
(934,305)
|
|||||||||||
|
Stock based compensation
|
500,000
|
499
|
111,932
|
-
|
112,431
|
|||||||||||||||
|
Shares issued for services
|
1,155,000
|
1,155
|
194,318
|
-
|
195,473
|
|||||||||||||||
|
Shares issued on debt conversion
|
100,000
|
100
|
4,900
|
-
|
5,000
|
|||||||||||||||
|
Common shares issued for capital lease obligation
|
711,417
|
711
|
163,810
|
-
|
164,521
|
|||||||||||||||
|
Warrants exercised
|
925,000
|
925
|
57,609
|
-
|
58,534
|
|||||||||||||||
|
Shares issued on earn out of contingent consideration
|
2,261,425
|
2,261
|
270,014
|
-
|
272,275
|
|||||||||||||||
|
Warrants issued for services
|
-
|
-
|
9,695
|
-
|
9,695
|
|||||||||||||||
|
Shares issued for debt extension
|
100,000
|
100
|
16,400
|
16,500
|
||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
(1,431,764)
|
(1,431,764)
|
|||||||||||||||
|
Balance at September 30, 2015
|
15,904,232
|
$
|
15,902
|
$
|
3,661,070
|
$
|
(5,208,612)
|
$
|
(1,531,640)
|
|||||||||||
|
Warrants
|
Exercise Price
|
Expiration
|
|||||||
|
2011 Private placement warrants
|
12,500
|
$
|
60.00
|
March 2018
|
|||||
|
2013 Series A warrants Senior convertible notes
|
5,200,000
|
$
|
0.05
|
June 2016-December 2016
|
|||||
|
2013 Series B warrants Senior convertible notes
|
6,000,000
|
$
|
0.06
|
June 2018-December 2018
|
|||||
|
2013 Issued with lease obligation
|
861,250
|
$
|
0.12
|
October 2016
|
|||||
|
2014 Acquired in U-Vend Canada merger
|
517,335
|
$
|
0.24
|
October 2015-January 2016
|
|||||
|
2014 Series A warrants Senior convertible notes
|
6,000,000
|
$
|
0.05
|
January 2017-November 2017
|
|||||
|
2014 Series B warrants Senior convertible notes
|
6,000,000
|
$
|
0.06
|
January 2019-November 2019
|
|||||
|
2014 Warrants for services
|
18,480
|
$
|
0.01
|
January 2016
|
|||||
|
2014 Warrants for services
|
420,000
|
$
|
0.35
|
August 2019-December 2019
|
|||||
|
2014 Warrants for services
|
35,000
|
$
|
0.24
|
January 2016
|
|||||
|
2014 Warrants for services
|
770,000
|
$
|
0.05
|
October 2015-December 2015
|
|||||
|
2014 Warrants for services
|
1,184,000
|
$
|
0.06
|
June 2018-December 2018
|
|||||
|
2014 Issued to Director for debt
|
729,166
|
$
|
0.24
|
November 2016-July 2017
|
|||||
|
2014 Issued with 2014 SPA convertible debt
|
243,334
|
$
|
0.35
|
August 2019-December 2019
|
|||||
|
2014 Issued with equipment financing obligation
|
200,000
|
$
|
0.35
|
October 2017
|
|||||
|
2014 issued with lease obligation
|
246,563
|
$
|
0.20
|
March 2017
|
|||||
|
2014 issued with lease obligation
|
483,889
|
$
|
0.18
|
May 2016
|
|||||
|
2014 Issued with promissory note
|
41,667
|
$
|
0.18
|
May 2017
|
|||||
|
2015 Issued with 2014 SPA convertible debt
|
116,668
|
$
|
0.35
|
January 2020-March 2020
|
|||||
|
2015 Issued with convertible financing obligation
|
52,600
|
$
|
0.35
|
January 2018
|
|||||
|
2015 Issued for services
|
400,400
|
$
|
0.35
|
February 2020-September 2020
|
|||||
|
2015 Issued with 2015 SPA convertible debt
|
651,667
|
|
$
|
0.40
|
April 2020- September 2020
|
||||
|
2015 Warrants issued for equipment
|
200,000
|
$
|
0.35
|
January 2020
|
|||||
|
30,384,519
|
|||||||||
|
September 30, 2015
|
December 31, 2014
|
|||||||
|
Balance at beginning of period
|
$
|
309,993
|
$
|
214,609
|
||||
|
Allocation of proceeds related to convertible and promissory notes to derivative
liabilities due to “down round” provision
|
9,696
|
285,269
|
||||||
|
Reclassification of warrant liability as additional paid in capital upon exercise of warrants
|
(3,534)
|
- | ||||||
|
Equipment purchased with warrants classified as derivative liabilities due to
“down round” provision
|
50,100
|
-
|
||||||
|
Allocation of proceeds related to subordinated convertible notes and
equipment financing obligation as derivative liabilities due to “down round” provision
|
-
|
6,951
|
||||||
|
Extinguishment of June 18, 2013, August 21, 2013 and October 17, 2013
senior convertible notes
|
-
|
(87,921)
|
||||||
|
Warrants classified as derivative liabilities due to inadequate shares
authorized to accommodate the exercise of all outstanding equity instruments
|
-
|
43,108
|
||||||
|
Adjustment of warrants classified as derivatives to additional-paid-in capital
as a result of adequate authorized due to reverse stock split on May 16, 2014
|
-
|
(52,833)
|
||||||
|
Unrealized gain on fair value adjustment
|
(62,343
|
)
|
(99,190
|
)
|
||||
|
$
|
303,912
|
$
|
309,993
|
|||||
|
For the period
|
June 30, 2016
|
June 30, 2017
|
June 30, 2018
|
June 30, 2019
|
June 30, 2020
|
Total
|
||||||||||||||||||
|
Sponsorship fee
|
$ | 374,650 | $ | 524,510 | $ | 636,905 | $ | 636,905 | $ | 636,905 | $ | 2,809,875 | ||||||||||||
|
Minimum royalty
|
224,790 | 374,650 | 449,580 | 524,510 | 674,370 | 2,247,900 | ||||||||||||||||||
|
Media commitment
|
149,860 | 149,860 | 149,860 | 149,860 | 149,860 | 749,300 | ||||||||||||||||||
|
Product in kind
|
1,499 | 1,499 | 1,499 | 1,499 | 1,499 | 7,495 | ||||||||||||||||||
|
Total commitment
|
$ | 750,799 | $ | 1,050,519 | $ | 1,237,844 | $ | 1,312,774 | $ | 1,462,634 | $ | 5,814,570 | ||||||||||||
|
|
Our limited operating history with our business model.
|
|
|
The low cash balance and limited financing currently available to us. We may in the near future have a number of obligations that we will be unable to meet without generating additional income or raising additional capital.
|
|
|
Further cost reductions or curtailment in future operations due to our low cash balance and negative cash flow.
|
|
|
Our ability to effect a financing transaction to fund our operations which could adversely affect the value of our stock.
|
|
|
Our limited cash resources may not be sufficient to fund continuing losses from operations.
|
|
|
The failure of our products and services to achieve market acceptance.
|
|
|
The inability to compete in our market, especially against established industry competitors with greater market presence and financial resources.
|
|
·
|
Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets;
|
|
·
|
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
|
|
·
|
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
|
|
31.1
|
Certification of Principal Executive Officer Pursuant to Rule 13a-14(a) and15d-14(a)
|
|
31.2
|
Certification of Principal Financial Officer Pursuant to Rule 13a-14(a) and15d-14(a)
|
|
32.1
|
Certification of Principal Executive and Chief Financial Officer Pursuant to 18 U.S.C. 1350
|
|
101.INS*
|
XBRL Instance Document
|
|
101.SCH*
|
XBRL Schema Document
|
|
101.CAL*
|
XBRL Calculation Linkbase Document
|
|
101.DEF*
|
XBRL Label Linkbase Document
|
|
101.PRE*
|
XBRL Presentation Linkbase Document
|
|
U-VEND, INC.
|
||
|
December 16, 2015
|
By:
|
/s/ Raymond Meyers
|
|
Raymond Meyers
Chief Executive Officer and Chief Financial Officer
(Principal Executive Officer and Principal Financial Officer
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|